The blood-brain barrier and immune function and dysfunction

Neurobiology of Disease

Volumn 37, Issue 1, 2010, Pages 26-32

  Banks, William A ^a,b   Erickson, Michelle A ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood brain barrier; Central nervous system; Cytokines; Interleukin 1; Lipopolysaccharide; Neuroimmune; Tumor necrosis factor; Vagus

Indexed keywords

CISPLATIN; GLYCOPROTEIN P; INSULIN; INTERLEUKIN 1; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NATALIZUMAB; PROTEIN P55; PROTEIN P75; RABIES VACCINE; TUMOR NECROSIS FACTOR;

BLOOD BRAIN BARRIER; CHRONIC PAIN; CLINICAL TRIAL; COGNITIVE DEFECT; CYTOKINE RELEASE; DIABETES MELLITUS; DRUG EFFICACY; DRUG TRANSPORT; ENCEPHALOMYELITIS; ENZYME ACTIVATION; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOPATHOLOGY; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PROTEIN TRANSPORT; RABIES; REVIEW; SEPSIS; SIGNAL TRANSDUCTION; VACCINATION;

ANIMALS; BLOOD-BRAIN BARRIER; CYTOKINES; HUMANS; LIPOPOLYSACCHARIDES; MODELS, NEUROLOGICAL; NEUROIMMUNOMODULATION;

EID: 70449529633     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2009.07.031     Document Type: Review

References (112)

1. Amar J., Burcelin R., Ruidavets J.B., Cani P.D., Fauvel J., Alessi M.C., Chamontin B., and Ferrieres J. Energy intake is associated with endotoxemia in apparently healthy men. Am. J. Clin. Nutr. 87 (2008) 1219-1223
2. Ancuta P., Kamat A., Kinstman K.J., Kim E.Y., Autissier P., Wurcel A., Zaman T., Stone D., Mefford M., Morgello S., Singer E.J., Wolinsky S.M., and Gabuzda D. Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS ONE 23 (2008) e2516
3. Andras I.E., Pu H., Deli M.A., Nath A., Hennig B., and Toborek M. HIV-1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells. J. Neurosci. Res. 74 (2003) 255-265
4. Avison M.J., Nath A., Greene-Avison R., Schmitt F.A., Bales R.A., Ethisham A., Greenberg R.N., and Berger J.R. Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia. J. Neurovirol. 10 (2004) 223-232
5. Banks W.A. Blood-brain barrier transport of cytokines: a mechanism for neuropathology. Curr. Pharm. Des. 11 (2005) 973-984
6. Banks W.A. Editorial: the blood-brain barrier as a cause of disease. Curr. Pharm. Des. 14 (2008) 1553-1554
7. Banks W.A., and Kastin A.J. The interleukins -1α, -1β, and -2 do not disrupt the murine blood-brain barrier. Int. J. Immunopharmacol. 14 (1992) 629-636
8. Banks W.A., Ortiz L., Plotkin S.R., and Kastin A.J. Human interleukin (IL) 1α, murine IL-1α and murine IL-1β are transported from blood to brain in the mouse by a shared saturable mechanism. J. Pharmacol. Exp. Ther. 259 (1991) 988-996
9. Banks W.A., Kastin A.J., and Broadwell R.D. Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation 2 (1995) 241-248
10. Banks W.A., Kastin A.J., Brennan J.M., and Vallance K.L. Adsorptive endocytosis of HIV-1gp120 by blood-brain barrier is enhanced by lipopolysaccharide. Exp. Neurol. 156 (1999) 165-171
11. Banks W.A., Farr S.A., La Scola M.E., and Morley J.E. Intravenous human interleukin-1α impairs memory processing in mice: dependence on blood-brain barrier transport into posterior division of the septum. J. Pharmacol. Exp. Ther. 299 (2001) 536-541
12. Banks W.A., Dohgu S., Nakaoke R., Lynch J.L., Fleegal-DeMotta M.A., Erickson M.A., and Vo T.Q. Nitric oxide isoenzymes regulate LPS-enhanced insulin transport across the blood-brain barrier. Endocrinology 149 (2008) 1514-1523
13. Bauer B., Hartz A.M.S., and Miller D.S. Tumor necrosis factor alpha and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier. Mol. Pharmacol. 71 (2007) 667-675
14. Baxter A.G. The origin and application of experimental autoimmune encephalomyelitis. Nat. Rev. Immunol. 7 (2007) 904-912
15. Begley D.J. ABC transporters and the blood-brain barrier. Curr. Pharm. Des. 10 (2004) 1295-1312
16. Blatteis C.M. Role of the OVLT in the febrile response to circulating pyrogens. In: Ermisch A., Landgraf R., and Ruhle H.J. (Eds). Circumventricular Organs and Brain Fluid Environment (1992), Elsevier, Amsterdam 409-412
17. Boven L.A., Middel J., Verhoef J., De Groot C.J., and Nottet H.S. Monocytes infiltration is highly associated with loss of tight junction protein zonula occludens in HIV-1-associated dementia. Neuropathol. Appl. Neurobiol. 26 (2000) 356-362
18. Brenchley J.M., Price D.A., Schacker T.W., Asher T.E., Silvestri G., Rao S., Kazzaz Z., Bornstein E., Lambotte O., Altmann D., Blazar B.R., Rodriguez B., Teixeira-Johnson L., Landay A., Martin J.N., Hecht F.M., Picker L.J., Lederman M.M., Deeks S.G., and Douek D.C. Microbial translocation is a cause of systemic immune activation in chronic HIV injection. Nat. Med. 12 (2006) 1365-1371
19. Broman T. Supravital analysis of disorders in the cerebrovascular permeability. Acta Psychiatr. 25 (1950) 19-31
20. Buhler L.A., Samara R., Guzman E., Wilson C.L., Krizanac-Bengez L., Janigro D., and Ethell D.W. Matrix metalloproteinase-7 facilitates immune access to the CNS in experimental autoimmune encephalomyelitis. BMC Neurosci. 10 (2009) 17
21. Candelario-Jalil E., Taheri S., Yang Y., Sood R., Grossetete M., Estrada E.Y., Fiebich B.L., and Rosenberg G.A. Cyclooxygenase inhibition limits blood-brain barrier disruption following intracerebral injection of tumor necrosis factor-a in the rat. J. Pharmacol. Exp. Ther. 323 (2007) 488-498
22. Cao C., Watanabe Y., Yamagata K., and Matsumura K. Involvement of cyclooxygenase-2 in LPS-induced fever and regulation of its mRNA by LPS in the rat brain. Am. J. Physiol. 272 (1997) R1712-R1725
23. Chi O.Z., Liu X., and Weiss H.R. Effects of 17beta-estradiol on blood-brain barrier disruption during focal ischemia in rats. Horm. Met. Res. 34 (2003) 530-534
24. Chou S., and Dix R.D. Viral infections and the blood-brain barrier. In: Neuwelt E.A. (Ed). Implications of the Blood-Brain Barrier and Its Manipulation Volume 2 (1989), Clinical Aspects. Plenum Publishing Corporation, New York 449-468
25. Coisne C., Lyck R., and Engelhardt B. Therapeutic targeting of leukocyte trafficking across the blood-brain barrier. Inflamm. Allergy Drug Targets 6 (2007) 210-222
26. Coisne C., Mao W., and Engelhardt B. Cutting edge: natalizumab blocks adhesion but not initial contact of human T cells to the blood-brain barrier in vivo in an animal model of multiple sclerosis. J. Immunol. 182 (2009) 5909-5913
27. Cremona S., Goujon E., Kelly K.W., Dantzer R., and Parnet P. Brain type I but not type II IL-1 receptors mediate the effects of IL-1 beta on behavior in mice. Am. J. Physiol. 274 (1998) R735-R740
28. Davson H. The blood-brain barrier. Physiology of the Cerebrospinal Fluid (1967), J. and A. Churchill, LTD., London 82-103
29. Davson H., and Segal M.B. Ontogenetic aspects of the cerebrospinal system. Physiology of the CSF and Blood-Brain Barriers (1996), CRC Press, Inc, Boca Rataon 607-662
30. De Vries H.E., Moor A.C., Blom-Roosemalen M.C., De Boer A.G., Breimer D.D., van Berkel T.J., and Kuiper J. Lymphocyte adhesion to brain capillary endothelial cells in vitro. J. Neuroimmunol. 52 (1994) 1-8
31. del Rey A., Monge-Arditi G., and Besedovsky H.O. Central and peripheral mechanisms contribute to the hypoglycemia induced by interleukin-1. Ann. N.Y. Acad. Sci. 840 (1998) 153-161
32. Deli M.A., Descamps L., Dehouck M.P., Cecchelli R., Joo F., Abraham C.S., and Torpier G. Exposure of tumor necrosis factor-α to luminal membrane of bovine brain capillary endothelial cells cocultured with astrocytes induces a delayed increase of permeability and cytoplasmic stress fiber formation of actin. J. Neurosci. Res. 41 (1995) 717-726
33. Didier N., Banks W.A., Creminon C., Dereuddre-Bosquet N., and Mabondzo A. HIV-1-induced production of endothelin-1 in an in vitro model of the human blood-brain barrier. Neuroreport 13 (2002) 1179-1183
34. Dohgu S., and Banks W.A. Lipopolysaccharide-enhanced transcellular transport of HIV-1 across the blood-brain barrier is mediated by the p38 mitogen-activated protein kinase pathway. Exp. Neurol. 210 (2008) 740-749
35. Dorheim M.A., Tracey W.R., Pollock J.S., and Grammas P. Nitric oxide synthase activity is elevated in brain microvessels in Alzheimer's disease. Biochem. Biophys. Res. Commun. 205 (1994) 659-665
36. Ellison M.D., Povlishock J.T., and Merchant R.E. Blood-brain barrier dysfunction in cats following recombinant interleukin-2 infusion. Cancer Res. 47 (1987) 5765-5770
37. Engelhardt B. The blood-central nervous system barriers actively control immune cell entry into the central nervous system. Curr. Pharm. Des. 14 (2008) 1555-1565
38. Etienne-Manneville S., Manneville J.B., Adamson P., Wilbourn B., Greenwood J., and Couraud P.O. ICAM-1-coupled cytoskeletal rearrangements and transendothelial lymphocyte migration involve intracellular calcium signaling in brain endothelial cell lines. J. Immunol. 165 (2000) 3375-3383
39. Fabry Z., Fitzsimmons K.M., Herlein J.A., Moninger T.O., Dobbs M.B., and Hart M.N. Production of the cytokines interleukin 1 and 6 by murine brain microvessel endothelium and smooth muscle pericytes. J. Neuroimmunol. 47 (1993) 23-34
40. Fiala M., Looney D.J., Stins M., Way D.D., Zhang L., Gan X., Chiappelli F., Schweitzer E.S., Shapshak P., Weinand M., Graves M.C., Witte M., and Kim K.S. TNF-α opens a paracellular route for HIV-1 invasion across the blood-brain barrier. Mol. Med. 3 (1997) 553-564
41. Ghoshal S., Witta J., Zhong J., de Villiers W., and Eckhardt E. Chylomicrons promote intestinal absorption of lipopolysaccharides. J. Lipid Res. 50 (2009) 90-97
42. Gianotti L., Alexander J.W., Eaves-Pyles T., and Fukushima R. Dietary fatty acids modulate host bacteriocidal response, microbial translocation and survival following blood transfusion and thermal injury. Clin. Nutr. 15 (1996) 291-296
43. Goehler L.E., Gaykema R.P., Nguyen K.T., Lee J.E., Tilders F.J., Maier S.F., and Watkins L.R. Interleukin-1 beta in immune cells of the abdominal vagus nerve: a link between the immune and nervous systems?. J. Neurosci. 19 (1999) 2799-2806
44. Gross P.M., Blasberg R.G., Fenstermacher J.D., and Patlak C.S. The microcirculation of rat circumventricular organs and the pituitary gland. Brain Res. Bull. 18 (1987) 73-85
45. Guillot F.L., and Audus K.L. Angiotensin peptide regulation of bovine brain microvessel endothelial cell monolayer permeability. J. Cardiovasc. Pharmacol. 18 (1991) 212-218
46. Hansen M.K., O'Connor K.A., Goehler L.E., Watkins L.R., and Maier S.F. The contribution of the vagus nerve in interleukin-1 beta-induced fever is dependent on dose. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280 (2001) R929-R934
47. Hartz A.M.S., Bauer B., Fricker G., and Miller D.S. Rapid modulation of P-glycoprotein-mediated transport at the blood-brain barrier by tumor necrosis factor-alpha and lipopolysaccharide. Mol. Pharmacol. 69 (2006) 462-470
48. Hofman F., Chen P., Incardona F., Zidovetzki R., and Hinton D.R. HIV-tat protein induces the production of interleukin-8 by human brain-derived endothelial cells. J. Neuroimmunol. 94 (1999) 28-39
49. Huber J.D. Diabetes, cognitive function, and the blood-brain barrier. Curr. Pharm. Des. 14 (2008) 1594-1600
50. Huber J.D., VanGilder R.L., and Houser K.A. Streptozotocin-induced diabetes progressively increases blood-brain barrier permeability in specific brain regions in rats. Am. J. Physiol. 291 (2006) H2660-H2668
51. Huber J.D., Hau V.S., Borg L., Campos C.R., Egleton R.D., and Davis T.P. Blood-brain barrier tight junctions are altered during a 72-h exposure to lamba-carrageenan-induced inflammatory pain. Am. J. Physiol. 283 (2002) H1531-H1537
52. Hurwitz A.A., Berman J.W., and Lyman W.D. The role of the blood-brain barrier in HIV infection of the central nervous system. Adv. Neuroimmunol. 4 (1994) 249-256
53. Jaeger L.B., Dohgu S., Lynch J.L., Fleegal-DeMotta M.A., and Banks W.A. Effects of lipopolysaccharide on the blood-brain barrier transport of amyloid bea protein: a mechanism for inflammation in the progression of Alzheimer's disease. Brain Behav Immun 23 (2009) 507-517
54. Johanson C.E., Duncan III J.A., Kling P.M., Brinker T., Stopa E.G., and Silverberg G.D. Multiplicity of cerebrospinal fluid functions: new challenges in health and disease. Cerebrospinal Fluid Res. 5 (2008) 10
55. Kanmogne G.D., Primeaux C., and Grammas P. HIV-1 gp120 proteins alter tight junction protein expression and brain endothelial cell permeability: implications for the pathogenesis of HIV-associated dementia. J. Neuropathol. Exp. Neurol. 64 (2005) 498-505
56. Kent S., Bluthe R.M., Dantzer R., Hardwick A.J., Kelley K.W., Rothwell N.J., and Vannice J.L. Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 9117-9120
57. Kobiler D., Lustig S., Gozes Y., Ben Nathan D., and Akov Y. Sodium dodecylsulphate induces a breach in the blood-brain barrier and enables a West Nile virus variant to penetrate into mouse brain. Brain Res. 496 (1989) 314-316
58. 2 levels in several brain areas as determined by microdialysis. Am. J. Physiol. 262 (1992) E246-E251
59. Langer-Gould A., and Steinman L. Progressive multifocal leukoencephalpoathy and multiple sclerosis: lessons from natalizumab. Curr. Neurol. Neurosci. Rep. 6 (2006) 253-258
60. Lassmann H. Models of multiple sclerosis: new insights into pathophysiology and repair. Curr. Opin. Neurol. 21 (2008) 242-247
61. Lee Y.W., Hennig B., Fiala M., Kim K.S., and Toborek M. Cocaine activates redox-regulated transcription factors and induces TNF-alpha expression in human brain endothelial cells. Brain Res. 920 (2001) 125-133
62. Li A., Li Z., Ma S., Su Q., Zhang S., Sun X., and Li G. Dysfunction of splenic macrophages in cirrhotic patients with hypersplenism and HBV infection. Am. J. Med. Sci. 336 (2008) 32-38
63. Liu H.C., Anday J.K., House S.D., and Chang S.L. Dual effects of morphine on permeability and apoptosis of vascular endothelial cells: morphine potentiates lipopolysaccharide-induced permeability and apoptosis of vascular endothelial cells. J. Neuroimmunol. 146 (2004) 13-21
64. Maes M., Kubera M., and Leunis J.C. The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro. Endocrinol. Lett. 29 (2008) 117-124
65. Mandi Y., Ocsovszki I., Szabo D., Nagy Z., Nelson J., and Molnar J. Nitric oxide production and MDR expression by human brain endothelial cells. Anticancer Res. 18 (1998) 3049-3052
66. Maness L.M., Kastin A.J., and Banks W.A. Relative contributions of a CVO and the microvascular bed to delivery of blood-borne IL-1α to the brain. Am. J. Physiol. 275 (1998) E207-E212
67. Marvel F.A., Chen C.-C., Badr N., Gaykema R.P.A., and Goehler L.E. Reversible inactivation of the dorsal vagal complex blocks lipopolysaccharide-induced social withdrawal and c-Fos expression in central autonomic nuclei. Brain Behav. Immun. 18 (2003) 123-134
68. MCCandless E.E., Zhang B., Diamond M.S., and Klein R.S. CSCR4 antagonism increases T cell trafficking in the central nerous system and improves survival from West Nile virus encephalitis. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 11270-11275
69. MCCandless E.E., Budde M., Lees J.R., Dorsey D., Lyng E., and Klein R.S. IL-1R signaling within the central nervous system regulates CXCL12 expression at the blood-brain barrier and disease severity during experimental autoimmune encephalomyelitis. J. Immunol. 183 (2009) 613-620
70. MCGuire T.R., Trickler W.J., Hock L., Vrana A., Hoie E.B., and Miller D.W. Release of prostaglandin E-2 in bovine brain endothelial cells after exposure to three unique forms of the antifungal drug amphotericin-B: role of COX-2 in amphotericin-B induced fever. Life Sci. 72 (2003) 2581-2590
71. Minami T., Okazaki J., Kawabata A., Kuroda R., and Okazaki Y. Penetration of cisplatin into mouse brain by lipopolysccharide. Toxicology 130 (1998) 107-113
72. Neuwelt E., Abbott N.J., Abrey L., Banks W.A., Blakley B., Davis T., Engelhardt B., Grammas P., Nedergaard M., Nutt J., Pardgridge W., Rosenberg G.A., Smith Q., and Drewes L.R. Strategies to advance translational research into brain barriers. Lancet Neurol. 7 (2008) 84-96
73. Ng Q.Y., Lee K.W., Byrne C., Ho T.F., and Lim C.L. Plasma endotoxin and immune responses during a 21-km road race under a warm and humid environment. Ann. Acad. Med. Singapore 37 (2008) 307-314
74. Nottet H.S., Persidsky Y., Sasseville V.G., Nukuna A.N., Bock P., Zhai Q.H., Sharer L.R., McComb R.D., Swindells S., Soderland C., and Gendelman H.E. Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain. J. Immunol. 156 (1996) 1284-1295
75. Osburg B., Peiser C., Domling D., Schomburg L., Ko Y.T., Voight K., and Bickel U. Effect of endotoxin on expression of TNF receptors and transport of TNF-alpha at the blood-brain barrier of the rat. Am. J. Physiol. 283 (2002) E899-E908
76. Osmers I., Bullard D.C., and Barnum S.R. PSGL-1 is not required for development of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 166 (2005) 193-196
77. Oztas B., Kucuk M., and Kaya M. Sex-dependent changes in blood-brain barrier permeability in epileptic rats following acute hyperosmotic exposure. Pharmacol. Res. 43 (2001) 469-472
78. Pan W., and Kastin A.J. Entry of EGF into brain is rapid and saturable. Peptides 20 (1999) 1091-1098
79. Pan W., and Kastin A.J. TNFα transport across the blood-brain barrier is abolished in receptor knockout mice. Exp. Neurol. 174 (2002) 193-200
80. Pan W., and Kastin A.J. Cytokine transport across the injured blood-spinal cord barrier. Curr. Pharm. Des. 14 (2008) 1620-1624
81. Persidsky Y., Stins M., Way D., Witte M.H., Weinand M., Kim K.S., Bock P., Gendelman H.E., and Fiala M. A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. J. Immunol. 158 (1997) 3499-3510
82. Peruzzo B., Pastor F.E., Blazquez J.L., Schobitz K., Pelaez B., Amat P., and Rodriguez E.M. A second look at the barriers of the medial basal hypothalamus. Exp. Brain Res. 132 (2000) 10-26
83. Pozzilli C., Bernardi S., Mansi L., Picozzi P., Iannotti F., Alfano B., Bozzao L., Lenzi G.L., Salvatore M., Conforti P., and Fieschi C. Quantitative assessment of the blood-brain barrier permeability in multiple sclerosis using 68-Ga-EDTA and positron emission tomography. J. Neurol. Neurosurg. Psych. 51 (1988) 1058-1062
84. Pu H., Tian J., Flora G., Lee Y.W., Nath A., Hennig B., and Toborek M. HIV-1 Tat protein upregulates inflammatory mediators and induces monocyte invasion into the brain. Mol. Cell. Neurosci. 24 (2003) 224-237
85. Pugh C.R., Fleshner M., Watkins L.R., Maier S.F., and Rudy J.W. The immune system and memory consolidation: a role for the cytokine IL-1β. Neurosci. Biobehav. Rev. 25 (2001) 29-41
86. Pussinen P.j., Vilkuna-Rautiainen T., Alfthan G., Palosuo T., Jauhiainen M., Sundvall J., Vesanen M., Mattila K., and Asikainen S. Severe periodontitis enhances macrophage activation via increased serum lipopolysaccharide. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 2174-2180
87. Qin L., Wu X., Block M.L., Liu Y., Breese G.R., Hong J.S., Knapp D.J., and Crews F.T. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. GLIA 55 (2007) 453-462
88. Quagliarello V.J., Wispelwey B., Long J., and Scheld W.M. Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat: characterization and comparison with tumor necrosis factor. J. Clin. Invest. 87 (1991) 1360-1366
89. Quan N., and Banks W.A. Brain-immune communication pathways. Brain Behav. Immun. 21 (2007) 727-735
90. Reese T.S., and Karnovsky M.J. Fine structural localization of a blood-brain barrier to exogenous peroxidase. J. Cell Biol. 34 (1967) 207-217
91. Reyes T.M., Fabry Z., and Coe C.L. Brain endothelial cell production of a neuroprotective cytokine, interleukin-6, in response to noxious stimuli. Brain Res. 851 (1999) 215-220
92. Romeo H.E., Tio D.L., Rahman S.U., Chiappelli F., and Taylor A.N. The glossopharyngeal nerve as a novel pathway in immune-to-brain communication: relevance to neuroimmune surveillance of the oral cavity. J. Neuroimmunol. 115 (2001) 91-100
93. Salkeni M.A., Lynch J.L., Price T.O., and Banks W.A. Lipopolysaccharide impairs blood-brain barrier P-glycoprotein function in mice through prostaglandin- and nitric oxide-independent pathways and nitric oxide-independent pathways. J Neuroimmune Pharmacology. J Neuroimmune Pharmacology 4 (2009) 276-282
94. Schulze-Topphoff U., Prat A., Prozorovski T., Siffrin V., Paterka M., Herz J., Bendix I., Ifergan I., Schadock I., More M.A., Van Horssen J., Schroter F., Smorodchenko A., Han M.H., Bader M., Steinman L., Aktas O., and Zipp F. Activiation of kinin receptor B1 limits encephalitogenic T lymphocyte recruitment to the central nervous system. Nat. Med. 15 (2009) 788-793
95. Sikkeland L.I., Skogstad M., Ovstebo R., Brusletto B., Haug K.B., Kongerud J., Eduard W., and Kierulf P. Circulating lipopolysaccharises in the blood from "bioprotein" production workers. Occup. Environ. Med. 65 (2008) 211-214
96. Simpson J.E., Newcombe J., Cuzner M.L., and Woodrofe M.N. Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis. J. Neuroimmunol. 84 (1998) 238-249
97. Spranger J., Verma S., Gohring I., Bobbert T., Seifert J., Sindler A.L., Pfeiffer A., Hileman S.M., Tschop M., and Banks W.A. Adiponectin does not cross the blood-brain barrier, but modifies cytokine expression of brain endothelial cells. Diabetes 55 (2006) 141-147
98. Stuve O. The effects of natalizumab on the innate and adaptive immune system in the central nervous system. J. Neurol. Sci. 274 (2008) 39-41
99. Szeto C.C., Kwan B.C., Chow K.M., Lai K.B., Chung K.Y., Leung C.B., and Li P.K. Endotoxemia is related to systemic inflammation and atherosclerosis in peritoneal dialysis patients. Clin. J. Am. Soc. Nephrol. 3 (2008) 431-436
100. Turowski P., Adamson P., and Greenwood J. Pharmacological targeting of ICAM-1 signaling in brain endothelial cells: potential for treating neuroinflammation. Cell. Mol. Neurobiol. 25 (2005) 153-170
101. Vadeboncoeur N., Segura M., Al-Numani D., Vanier G., and Gottschalk M. Proinflammatory cytokine and chemokine release by human brain microvascular endothelial cells stimulated by Streptococcus suis serotype 2. FEMS Immunol. Med. Microbiol. 35 (2003) 49-58
102. van Dam A.M., De Vries H.E., Kuiper J., Zijlstra F.J., De Boer A.G., Tilders F.J.H., and Berkenbosch F. Interleukin-1 receptors on rat brain endothelial cells: a role in neuroimmune interaction?. FASEB J. 10 (1996) 351-356
103. Verma S., Nakaoke R., Dohgu S., and Banks W.A. Release of cytokines by brain endothelial cells: a polarized response to lipopolysaccharide. Brain Behav. Immun. 20 (2006) 449-455
104. Vidal E.L., Patel N.A., Wu G., Fiala M., and Chang S.L. Interleukin-1 induces the expression of μ opioid receptors in endothelial cells. Immunopharmacology 38 (1998) 261-266
105. Watkins L.R., Maier S.F., and Goehler L.E. Cytokine-to-brain communication: a review and analysis of alternative mechanisms. Life Sci. 57 (1995) 1011-1026
106. Wetzel M.A., Steele A.D., Eisenstein T.K., Adler M.W., Henderson E.E., and Rogers T.J. Mu-opioid induction of monocyte chemoattractant protein-1, RANTES, and IFN-gamma-inducible protein-10 expression in human peripheral blood mononuclear cells. J. Immunol. 165 (2000) 6519-6524
107. Willis C.L., and Davis T.P. Chronic inflammatory pain and the neurovascular unit: a central role for glia in maintaining BBB integrity?. Curr. Pharm. Des. 14 (2008) 1625-1643
108. Wispelwey B., Lesse A.J., Hansen E.J., and Scheld W.M. Haemophilus influenzae lipopolysaccharide-induced blood brain barrier permeability during experimental meningitis in the rat. J. Clin. Invest. 82 (1988) 1339-1346
109. Xaio H., Banks W.A., Niehoff M.L., and Morley J.E. Effect of LPS on the permeability of the blood-brain barrier to insulin. Brain Res. 896 (2001) 36-42
110. Xin L., and Blatteis C.M. Hypothalamic neuronal responses to interleukin-6 in tissue slices: effects of indomethacin and naloxone. Brain Res. Bull. 29 (1992) 27-35
111. Yu C., Kastin A.J., Tu H., Waters S., and Pan W. TNF activates P-glycoprotein in cerebral microvascular endothelial cells. Cell. Physiol. Biochem. 20 (2007) 853-858
112. Zhang R., Miller R.G., Gascon R., Champion S., Katz J., Lancero M., Narvaez A., Honrada R., Ruvalcaba D., and McGrath M.S. Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS). J. Neuroimmunol. 206 (2009) 121-124